Canada vs United States of America: Treatment success rate for patients treated for MDR-TB
Canada
87.0%
in 2014
United States of America
87.0%
in 2021
Canada rank
27th
United States of America rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Canada
- United States of America
How they compare
Canada currently reports 87.0% against 87.0% in United States of America, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2004 it was Canada ahead.
Canada ranks 27th and United States of America ranks 27th of 163 countries.
Across the 2 decades both report, Canada averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Canada | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.0% | 69.6% | 0.6% | United States of America |
| 2010s | 79.4% | 73.0% | 6.4% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Canada or United States of America?
- Canada, at 87.0% against 87.0% in United States of America as of 2014.
- What is the difference in treatment success rate for patients treated for mdr-tb between Canada and United States of America?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and United States of America?
- 10 years are reported by both, from 2004 to 2014.
- How do Canada and United States of America rank globally for treatment success rate for patients treated for mdr-tb?
- Canada ranks 27th and United States of America ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.